ESAB (ESAB)
NYSEIndustrialsIndustrial - MachinerySnapshot 2026-11-04
$78.36+3.04%
Close 2026-11-04 · 1-day change
NYSEIndustrialsIndustrial - MachinerySnapshot 2026-11-04
Research Workspace
Put ESAB beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Industrial Machinery & Supplies & Components is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Recent financial performance freshly dropped to the bottom half of its industry.
View ThesisRevenue growth is accelerating — up about 11% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 52% in its worst 12-month stretch.
View RiskESAB's organic growth and margin expansion must keep compounding to justify the price. Revenue grew 13.3% year over year in the latest quarter. However, the company missed its earnings target by 2.3%. ESAB trades at 14 times earnings versus a 25 times peer median. This discount reflects modest expectations for future growth. The recent financial performance has dropped to the bottom half of its industry. This shift has broken the core thesis for the stock. Peer multiples imply a price about 26% above where it trades. The thesis has broken, and this read is provisional.
Trailing returns as of 2026-11-04. ESAB is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 11 analysts currently covering ESAB (as of Nov 2026).
Based on 3 Wall Street analysts offering 12-month price targets for ESAB in the last 4 months.
Continue this research
Compare ESAB with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| ESAB Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-11-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Industrial Machinery & Supplies & Components — fair value, gap to price, and forward P/E.
Compare the value case
Put ESAB next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Reiterate and raise 2026 financial outlook
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $78.36
The last 12 months of price, then the range of analyst 12-month targets from today’s $78.36.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Specific 2026 EPS guidance confirms growth trajectory.
Advances: Focus on organic growth and margin expansion
Margin expansion confirms objective 3 despite earnings miss.
Legal liability could impact financial outlook and operations.
Advances: Complete and integrate Eddyfi acquisition
Eddyfi integration supports growth and strategic objectives.
Advances: Reiterate and raise 2026 financial outlook
Record sales support growth and 2026 outlook.
Advances: Complete Eddyfi acquisition
Eddyfi acquisition closing ahead of schedule supports growth objectives.
Advances: Increase revenue growth
Sales beat indicates strong revenue growth trajectory.
Advances: Enhance gross profit margins
Positive margin outlook supports management's objective.